This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nagatani, G. Articles by Kohno, K. Search for Related Content PubMed PubMed Citation Articles by Nagatani, G. Articles by Kohno, K.

Transcriptional Activation of the Human HMG1 Gene in Cisplatin-resistant Human Cancer Cells¹

Departments of Molecular Biology [G. N., M. N., H. T., T. Is., K. Ka., T. Im., H. I., K. Ko.] and Otolaryngology [K. M.], School of Medicine, University of Occupational and Environmental Health, Fukuoka 807-8555, Japan

The nonhistone chromosomal protein, high mobility group 1 (HMG1), which is ubiquitously expressed in higher eukaryotic cells, preferentially binds to cisplatin-modified DNA. The observation that HMG1 is overexpressed in cisplatin-resistant human cancer cells suggests that cisplatin resistance may be closely associated with HMG1. To decipher the mechanism of HMG1 overexpression in cisplatin-resistant cells, we isolated two overlapping genomic DNA clones containing the entire human HMG1 gene. These clones, which span 15 kb of contiguous DNA, include 5 kb of the 5' flanking region as well as the entire coding sequence. We sequenced 1500 bp upstream of the first exon. The segment proximal to the transcription initiation site did not contain a TATA box but did possess an activating transcription factor site, an activator protein-2 site, one CCAAT box, and two CCAAT-binding transcription factor/nuclear factor-1 (CTF/NF-1) sites. HMG1 promoter activity was 3–10-fold higher in cisplatin-resistant KB-CP20 cells than in parental KB cells. An in vivo footprint experiment showed several differences of dimethyl sulfate modifications between KB and KB-CP20 cells in the area around the CTF/NF-1 sites. In addition, electrophoretic gel mobility shift assays showed that binding of a nuclear factor from cisplatin-resistant cells to the CTF/NF-1 site was significantly higher than the binding of the same factor from parental cells. Semiquantitative reverse transcription-PCR and Western blot analysis also showed that expression of CTF/NF-1 was 3–20-fold higher in the resistant cell line than in its parental counterpart. These findings suggest that, in cisplatin-resistant cells, the expression of HMG1 gene product is enhanced at the transcriptional level and that this probably occurs through the enhanced expression of the CCAAT binding factor, CTF/NF-1.

This article has been cited by other articles:

				S. C. Roemer, J. Adelman, M. E. A. Churchill, and D. P. Edwards Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding Nucleic Acids Res., June 1, 2008; 36(11): 3655 - 3666. [Abstract] [Full Text] [PDF]

				J. E. Ellerman, C. K. Brown, M. de Vera, H. J. Zeh, T. Billiar, A. Rubartelli, and M. T. Lotze Masquerader: High Mobility Group Box-1 and Cancer Clin. Cancer Res., May 15, 2007; 13(10): 2836 - 2848. [Abstract] [Full Text] [PDF]

				J. Cleary, K. V. Sitwala, M. S. Khodadoust, R. P. S. Kwok, N. Mor-Vaknin, M. Cebrat, P. A. Cole, and D. M. Markovitz p300/CBP-associated Factor Drives DEK into Interchromatin Granule Clusters J. Biol. Chem., September 9, 2005; 280(36): 31760 - 31767. [Abstract] [Full Text] [PDF]

				M. Stros, T. Ozaki, A. Bacikova, H. Kageyama, and A. Nakagawara HMGB1 and HMGB2 Cell-specifically Down-regulate the p53- and p73-dependent Sequence-specific Transactivation from the Human Bax Gene Promoter J. Biol. Chem., February 22, 2002; 277(9): 7157 - 7164. [Abstract] [Full Text] [PDF]